Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Walgreens Boots Alliance, Inc.    WBA

WALGREENS BOOTS ALLIANCE, INC.

(WBA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/19/2020 11/20/2020 11/23/2020 11/24/2020 11/25/2020 Date
37.85(c) 37.53(c) 37.98(c) 38.52(c) 39.07(c) Last
12 780 945 9 022 607 8 214 111 8 792 033 6 644 001 Volume
-0.99% -0.85% +1.20% +1.42% +1.43% Change
More quotes
Financials (USD)
Sales 2021 143 B - -
Net income 2021 3 175 M - -
Net Debt 2021 13 736 M - -
P/E ratio 2021 10,5x
Yield 2021 4,86%
Sales 2022 148 B - -
Net income 2022 3 470 M - -
Net Debt 2022 12 374 M - -
P/E ratio 2022 9,49x
Yield 2022 5,01%
Capitalization 33 831 M 33 831 M -
EV / Sales 2021 0,33x
EV / Sales 2022 0,31x
Nbr of Employees 277 000
Free-Float 61,1%
More Financials
Company
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (83.4%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.1% of net sales) and International (9.9%). At the end of August 2019, the activity is ensured through 13,882 outlets (including 9,277 in the United... 
Sector
Drug Retailers
Calendar
01/07Earnings Release
More about the company
Notations Surperformance© of Walgreens Boots Alliance, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about WALGREENS BOOTS ALLIANCE, INC.
11/23WALGREENS BOOTS ALLIANCE : Reinvents Nation's Largest Health and Wellbeing-cente..
AQ
11/20GLOBAL MARKETS LIVE: Pfizer, General Motors, Alphabet…
11/19Walgreens offers 30-minute pickup for online shoppers
RE
11/19WALGREENS : Reinvents Nation's Largest Health and Wellbeing-centered Loyalty Pro..
BU
11/18WALGREENS BOOTS ALLIANCE, INC. : Ex-dividend day for
FA
11/17Wall Street closes lower as shutdown worries loom
RE
11/17Walgreens, Boston Scientific fall; Tesla, Paramount rise
AQ
11/17Walgreens, Boston Scientific fall; Tesla, Paramount rise
AQ
11/17WALGREENS : Wins 2020 Citizens Award for Get a Shot. Give a Shot. Program
BU
11/17S&P 500, Dow pull back from record highs as shutdown worries loom
RE
11/17Amazon launches online pharmacy in new contest with drug retail
RE
11/17Walgreens Down Over 9%, Worst Performer in the DJIA So Far Today -- Data Talk
DJ
11/17Stock Futures Edge Down After Dow Hits Record
DJ
11/17TESLA, T-MOBILE, WALMART, WALGREENS : What to Watch When the Stock Market Opens ..
DJ
11/17S&P, Dow futures retreat as coronavirus cases spike
RE
More news
News in other languages on WALGREENS BOOTS ALLIANCE, INC.
11/20WALGREENS : erfindet mit myWalgreens : das größte auf Gesundheit und Wohlbefinde..
11/20Le plan de relance redevient tendance aux Etats-Unis
11/20EN DIRECT DES MARCHES : Suez / Veolia, Altice, Europcar, Deinove, Poxel, Novarti..
11/19WALGREENS BOOTS ALLIANCE : Pour offrir aux clients de nombreux avantages supplém..
11/17Wall Street clôture en baisse, le coronavirus inquiète encore
More news
Analyst Recommendations on WALGREENS BOOTS ALLIANCE, INC.
More recommendations
Chart WALGREENS BOOTS ALLIANCE, INC.
Duration : Period :
Walgreens Boots Alliance, Inc. Technical Analysis Chart | WBA | US9314271084 | MarketScreener
Technical analysis trends WALGREENS BOOTS ALLIANCE, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Average target price 39,78 $
Last Close Price 39,07 $
Spread / Highest target 10,1%
Spread / Average Target 1,81%
Spread / Lowest Target -15,5%
EPS Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
James Kehoe Global Chief Financial Officer & Executive VP
Sector and Competitors